Humana (HUM) Q3 2025 Earnings Transcript Summary
Humana (HUM) reported Q3 2025 earnings, with management reaffirming full-year adjusted EPS guidance at approximately $17. The company noted operational constraints and no adverse medical cost trends, but indicated limited share repurchase activity and challenges with Stars revenue headwinds.
Tickers: $HUM
Topics: earnings guidance investment spending medical cost trends operational constraints share repurchases